Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Current Assets (2023 - 2025)

Bioharvest Sciences has reported Current Assets over the past 3 years, most recently at $30.5 million for Q4 2025.

  • For Q4 2025, Current Assets rose 288.24% year-over-year to $30.5 million; the TTM value through Dec 2025 reached $30.5 million, up 288.24%, while the annual FY2025 figure was $30.5 million, 288.24% up from the prior year.
  • Current Assets was $30.5 million for Q4 2025 at Bioharvest Sciences, up from $17.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $30.5 million in Q4 2025 and bottomed at $7.9 million in Q1 2024.
  • The 3-year median for Current Assets is $9.3 million (2024), against an average of $12.3 million.
  • Year-over-year, Current Assets decreased 13.21% in 2024 and then surged 288.24% in 2025.
  • Over 3 years, Current Assets stood at $9.1 million in 2023, then dropped by 13.21% to $7.9 million in 2024, then surged by 288.24% to $30.5 million in 2025.
  • The last three reported values for Current Assets were $30.5 million (Q4 2025), $17.8 million (Q3 2025), and $10.3 million (Q2 2025) per Business Quant data.